P. Uusimaa et al., Plasma vasoactive peptides after acute myocardial infarction in relation to left ventricular dysfunction, INT J CARD, 69(1), 1999, pp. 5-14
Citations number
46
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
We measured plasma concentrations of vasoactive peptides in 32 patients wit
h acute myocardial infarction and evaluated their value as markers of left
ventricular dysfunction. Plasma levels of atrial natriuretic peptide (ANP),
the N-terminal fragment of proANP (NT-proANP), B-type natriuretic peptide
(BNP) and endothelin-1 were measured serially by radioimmunoassays. The inf
arct size was estimated from the creatine kinase MB release curve. Coronary
angiography and left ventricular cineangiography were performed in all pat
ients during hospitalization and 6 months later in 15 patients. Myocardial
infarction caused an increase in vasoactive peptides, the highest values fo
r ANP (36.5+/-6.79 pmol/l), NT-proANP (1130+/-170 pmol/l) and endothelin-1
(9.72+/-0.68 pmol/l) being found on admission and those for BNP (56.0+/-7.1
3 pmol/l) on Day 2. Plasma levels of natriuretic peptides were dependent on
infarct size, its location and degree of myocardial dysfunction and that o
f BNP also on infarct artery patency. Plasma endothelin-1 level was higher
in patients with TIMI 3 than TIMI 0-2 flow. Plasma vasoactive peptides rema
ined elevated during the 6-month follow-up period and they were dependent o
n the degree of myocardial dysfunction. BNP measured on any day of hospital
ization showed the best correlation with ejection fraction measured during
the acute phase of infarction or at 6 months. The results show that BNP is
the best indicator of left ventricular dysfunction after myocardial infarct
ion and its reliability is not dependent on the time point of measurement.
(C) 1999 Elsevier Science ireland Ltd. All rights reserved.